340 related articles for article (PubMed ID: 35118826)
41. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.
Cohen N; Minshall ME; Sharon-Nash L; Zakrzewska K; Valentine WJ; Palmer AJ
Pharmacoeconomics; 2007; 25(10):881-97. PubMed ID: 17887808
[TBL] [Abstract][Full Text] [Related]
42. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
[TBL] [Abstract][Full Text] [Related]
43. Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - Significance of pregnancy planning and prepregnancy HbA1c.
Żurawska-Kliś M; Kosiński M; Kuchnicka A; Rurka M; Hałucha J; Wójcik M; Cypryk K
Diabetes Res Clin Pract; 2021 Feb; 172():108628. PubMed ID: 33358970
[TBL] [Abstract][Full Text] [Related]
44. Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index.
Leelarathna L; Thabit H; Wilinska ME; Bally L; Mader JK; Pieber TR; Benesch C; Arnolds S; Johnson T; Heinemann L; Hermanns N; Evans ML; Hovorka R
J Diabetes Sci Technol; 2020 Mar; 14(2):277-283. PubMed ID: 30931606
[TBL] [Abstract][Full Text] [Related]
45. Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial.
Moreno-Fernandez J; Gómez FJ; Gálvez Moreno MÁ; Castaño JP
J Diabetes Res; 2016; 2016():4171789. PubMed ID: 28004007
[No Abstract] [Full Text] [Related]
46. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
[TBL] [Abstract][Full Text] [Related]
47. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning.
Cyganek K; Hebda-Szydlo A; Katra B; Skupien J; Klupa T; Janas I; Kaim I; Sieradzki J; Reron A; Malecki MT
Diabetes Technol Ther; 2010 Jan; 12(1):41-7. PubMed ID: 20082584
[TBL] [Abstract][Full Text] [Related]
48. Effectiveness of Continuous Subcutaneous Insulin Infusion on Parental Quality of Life and Glycemic Control Among Children With T1D: Meta-Analysis.
Li AY; So WK; Leung DY
Worldviews Evid Based Nurs; 2018 Oct; 15(5):394-400. PubMed ID: 30033649
[TBL] [Abstract][Full Text] [Related]
49. Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR Study.
Picard S; Hanaire H; Reznik Y; Benhamou PY; Fendri S; Dufaitre L; Leutenegger E; Guerci B
Diabetes Technol Ther; 2018 Jun; 20(6):403-412. PubMed ID: 29847735
[TBL] [Abstract][Full Text] [Related]
50. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
51. Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study.
Alderisio A; Bozzetto L; Franco L; Riccardi G; Rivellese AA; Annuzzi G
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1110-1117. PubMed ID: 31371264
[TBL] [Abstract][Full Text] [Related]
52. Association of the use of diabetes technology with HbA1c and BMI-SDS in an international cohort of children and adolescents with type 1 diabetes: The SWEET project experience.
Marigliano M; Eckert AJ; Guness PK; Herbst A; Smart CE; Witsch M; Maffeis C;
Pediatr Diabetes; 2021 Dec; 22(8):1120-1128. PubMed ID: 34716736
[TBL] [Abstract][Full Text] [Related]
53. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N
Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165
[TBL] [Abstract][Full Text] [Related]
54. HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment.
Scott ES; McGrath RT; Januszewski AS; Calandro D; Hardikar AA; O'Neal DN; Fulcher G; Jenkins AJ
BMJ Open; 2019 Dec; 9(12):e033059. PubMed ID: 31888933
[TBL] [Abstract][Full Text] [Related]
55. Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials.
Zhou Y; Sardana D; Kuroko S; Haszard JJ; de Block MI; Weng J; Jefferies C; Wheeler BJ
Diabet Med; 2024 Mar; 41(3):e15280. PubMed ID: 38197238
[TBL] [Abstract][Full Text] [Related]
56. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
Reid LJ; Gibb FW; Colhoun H; Wild SH; Strachan MWJ; Madill K; Dhillon B; Forbes S
Diabetologia; 2021 Aug; 64(8):1725-1736. PubMed ID: 33966091
[TBL] [Abstract][Full Text] [Related]
57. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS).
Little SA; Leelarathna L; Walkinshaw E; Tan HK; Chapple O; Lubina-Solomon A; Chadwick TJ; Barendse S; Stocken DD; Brennand C; Marshall SM; Wood R; Speight J; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JA
Diabetes Care; 2014 Aug; 37(8):2114-22. PubMed ID: 24854041
[TBL] [Abstract][Full Text] [Related]
58. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
[TBL] [Abstract][Full Text] [Related]
59. Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study.
Garg SK; Voelmle MK; Beatson CR; Miller HA; Crew LB; Freson BJ; Hazenfield RM
Diabetes Care; 2011 Mar; 34(3):574-9. PubMed ID: 21278138
[TBL] [Abstract][Full Text] [Related]
60. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
